Sharon Mavroukakis
- Oncology top 0.1%
- Immunology top 0.1%
- Molecular Biology top 5%
- Genetics top 0.5%
- Biomedical Engineering top 2%
- Co-authors
- Steven A. RosenbergRichard M. SherrySuzanne L. TopalianJames Chih‐Hsin YangNicholas P. RestifoLinda Rogers-FreezerJohn R. WunderlichDonald E. White
- Topics
- Immunotherapy and Immune Responses (18 papers)Cancer Immunotherapy and Biomarkers (9 papers)Virus-based gene therapy research (8 papers)
- Cited by
- ImmunologyOncologyBiotechnology
- Partner nations
- United StatesAustraliaMalaysia
In The Last Decade
Sharon Mavroukakis
33 papers receiving 10.3k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Oncology 7.6k
- Immunology 7.0k
- Molecular Biology 2.3k
- Genetics 1.9k
- Biomedical Engineering 997
Countries citing papers authored by Sharon Mavroukakis
This map shows the geographic impact of Sharon Mavroukakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Mavroukakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Mavroukakis more than expected).
Fields of papers citing papers by Sharon Mavroukakis
This network shows the impact of papers produced by Sharon Mavroukakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Mavroukakis. The network helps show where Sharon Mavroukakis may publish in the future.
Co-authorship network of co-authors of Sharon Mavroukakis
This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Mavroukakis. A scholar is included among the top collaborators of Sharon Mavroukakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Mavroukakis. Sharon Mavroukakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 8 | |
| 4 | 48 | |
| 5 | 16 | |
| 6 | 9 | |
| 7 | 2 | |
| 8 | 2 | |
| 9 | 139 | |
| 10 | Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitisbreakdown → | 537 |
| 11 | Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytesbreakdown → | 1961 |
| 12 | 28 | |
| 13 | 214 | |
| 14 | 365 | |
| 15 | 380 | |
| 16 | 48 | |
| 17 | Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanomabreakdown → | 1234 |
| 18 | 91 | |
| 19 | 85 | |
| 20 | Phase I Study of the Intravenous Administration of AttenuatedSalmonella typhimuriumto Patients With Metastatic Melanomabreakdown → | 565 |
About Sharon Mavroukakis
Sharon Mavroukakis is a scholar working on Immunology, Oncology and Biotechnology, having authored 36 papers that have together received 10.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (18 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Virus-based gene therapy research (8 papers). The work is most often cited by research in Immunology (7.0k citations), Oncology (7.6k citations) and Biotechnology (780 citations). Sharon Mavroukakis has collaborated with scholars based in United States, Australia and Malaysia. Frequent co-authors include Steven A. Rosenberg, Richard M. Sherry, Suzanne L. Topalian, James Chih‐Hsin Yang, Nicholas P. Restifo, Linda Rogers-Freezer, John R. Wunderlich, Donald E. White, Kathleen E. Morton and Richard E. Royal. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.